ThinkCyte
Keisuke Wagatsuma is a highly experienced professional in the fields of immunology and drug discovery. Currently serving as a Senior Scientist and Project Manager at ThinkCyte, Keisuke leads a Cell Therapy Group, collaborating with pharmaceutical companies and academic researchers. As Co-Founder and CEO of ENIC Immunology K.K. since September 2023, Keisuke continues to contribute to innovative research. Prior roles include Chief Research Scientist at Mitsubishi Tanabe Pharma Corporation, where Keisuke directed drug discovery initiatives in immunology and inflammation, establishing new research projects and screening systems. Academic experience includes an Assistant Professorship at Shiga University of Medical Sciences, focusing on T cell receptor mechanisms, and a research role at Kyoto University. Keisuke holds a Ph.D. from Kyoto University and a Master’s degree from Tottori University.
This person is not in any offices
ThinkCyte
1 followers
ThinkCyte’s mission is to provide scientists and biomedical professionals with a transformational single-cell technology that accelerates biological discoveries and enable the development of novel treatments and diagnostics through the integration of advanced hardware, machine learning, and biotechnology.